DSM is active in nutritional and pharma ingredients, performance materials and industrial chemicals. DSM’s products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paints, housing and electrics and electronics.
DSM has sales of over Euro9bn and around 23,500 employees (2008). The company is headquartered in the Netherlands, with locations in Europe, US, Asia, Africa, and Australia.
Company movements
In October 2009, DSM completed the sale of DSM Energie Holding (DSM Energy) to The Abu Dhabi National Energy Co PJSC (TAQA). For more on this story please see UAE's TAQA completes €285m purchase of Dutch DSM Energy and Dutch DSM to sell energy, urea businesses on ICIS news.
Also in October 2009, DSM finalised the sale of its urea-licensing business subsidiary Stamicarbon to Maire Tecnimont.
In June 2009, DSM agreed to acquire Biopract for an undisclosed sum. For more on this story please see DSM to buy Germany-based biogas firm Biopract.
In February 2009, DSM said that the previously announced sale of DSM Special Products to Arsenal Capital Partners will not be completed. The transaction was originally announced on 3 March 2008.
In December 2008, DSM agreed to sell its Solutech filtration products business to Lydall for an undisclosed sum.
In April 2008, DSM said that it plans to acquire the US-based Polymer Technology Group (PTG) in order to expand its biomedical polymers business. The acquisition is subject to regulatory approval. Financial details have not been given.
DSM's activities are grouped into four clusters: Nutrition, Pharma, Performance Materials and Industrial Chemicals.
Nutrition
The Nutrition cluster comprises of:
DSM Nutritional Products; and
DSM Food Specialties.
Its main customers are food, beverages, feed and flavour/fragrance companies. The activities in this cluster include biotechnology (including fermentation, genomics and biocatalysis), organic chemistry and formulation technologies and on the company’s broad application knowledge.
Pharma
The Pharma cluster comprises of:
DSM Pharmaceutical Products; and
DSM Anti-Infectives.
DSM is a supplier to the pharmaceutical industry, it claims that around 40% of today’s top-selling medicines in the world contain ingredients developed and produced by DSM.
Performance Materials
The Performance Materials cluster comprises of:
DSM Engineering Plastics;
DSM Dyneema;
DSM Resins; and
DSM Elastomers.
Its products are used in a wide variety of end-use markets: the automotive industry, the aviation industry, the electrics and electronics industry, the sports and leisure industries, the coatings industry and the construction industry.
Polymer Intermediates
The Polymer Intermediates segment consists of:
DSM Fibre Intermediates
DSM is the global leader in the supply and production technology of caprolactam, the raw material for Nylon-6.
Base Chemicals and Materials
The Base Chemicals and Materials segment comprises of:
DSM Agro;
DSM Elastomers; and
DSM Melamine.
DSM produces basic materials for plastics and materials, high-grade construction materials for medical applications, cars and electronic appliances.
DSM
Strategy & Financial Highlights
DSM states that after successfully completing its strategy “Vision 2005 Focus and Value” in 2006, it will focus on its five year strategy of “Vision 2010 Building on Strengths” in 2007. The new strategy will focus on accelerated growth and expansion of the specialty content of its portfolio, accelerated innovation, and expansion in emerging economies. The overall objective of the strategy is “strong value creation”. (Edited from: “Message from the chairman”, “Objectives Vision 2010 – Building on Strengths"). ICIS also provides you with key financial data listed in table form.
More about DSM Strategy & Financial Highlights
News:
Get news on DSM plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database